LINC02436: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC02436

NCBI ID: G101928877

Other Name(s): long intergenic non-protein coding RNA 2436 | Long intergenic non-protein coding RNA 2436

LINC02436: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC02436 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified using RNA sequencing (RNA-seq) data. It is characterized by its unique 3'-end, open reading frame (ORF) and its absence of any protein coding regions. Despite its small size, LINC02436 has been shown to play a significant role in various cellular processes, including cell adhesion, migration, and the regulation of gene expression.

The search for potential drug targets and biomarkers has become an increasingly important area of research in the pharmaceutical industry. Drug targets are proteins that are involved in the development of diseases and are targeted by drugs to inhibit their activity. Biomarkers are molecules that are derived from biological systems and can be used as indicators of the presence or absence of a particular disease or condition.

In this article, we will explore the potential of LINC02436 as a drug target and biomarker. We will discuss the current understanding of LINC02436's function, the potential druggable sites, and the potential clinical applications of LINC02436-based therapeutics.

Current Understanding of LINC02436's Function

LINC02436 is a long non-coding RNA that is expressed in various tissues and cells. It has been shown to play a role in the regulation of cell adhesion, migration, and the development of tissues such as the brain.

One of the most significant functions of LINC02436 is its role in cell adhesion. It has been shown to be involved in the regulation of tight junction formation, which is a critical process that helps to maintain the integrity of tissues and is critical for various physiological processes, including cell signaling and stem cell maintenance.

In addition to its role in cell adhesion, LINC02436 has also been shown to be involved in the regulation of cell migration. It has been shown to play a role in the regulation of the movement of neurons, which is critical for the development and function of the nervous system.

Potential Druggable Sites

The lack of protein coding regions in LINC02436 makes it an attractive target for small molecules. Several studies have identified potential druggable sites in the ORF of LINC02436.

One of the most promising potential druggable sites is located in the first exon of the ORF. This site is conserved across various species and has been shown to be involved in the regulation of gene expression. Additionally, this site is also known to be involved in the regulation of protein stability, which could be an attractive target for small molecules that target protein stability.

Another potential druggable site is located in the second exon of the ORF. This site is also conserved across various species and has been shown to be involved in the regulation of gene expression. Additionally, this site is also known to be involved in the regulation of protein stability, which could be an attractive target for small molecules that target protein stability.

Potential Clinical Applications

The potential clinical applications of LINC02436-based therapeutics are vast. One of the most promising applications is the treatment of cancer. LINC02436 has been shown to play a role in the regulation of cell adhesion and migration, which could be useful for the treatment of cancer cells that are characterized by the loss of cell adhesion and

Protein Name: Long Intergenic Non-protein Coding RNA 2436

More Common Targets